Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Oncology Letters|October 23, 2018
Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinomaSatoshi Matsukuma, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, et al.BMC Cancer|February 2, 2024
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancerKei Furuya, Masao Nakajima, Ryouichi Tsunedomi, et al.British Journal of Cancer|October 19, 2019
Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancerTaichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, et al.British Journal of Cancer|September 7, 2019
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancerTaichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 10, 2019
Identification of a Promiscuous Epitope Peptide Derived From HSP70Hiroto Matsui, Shoichi Hazama, Koji Tamada, et al.Anticancer Research|December 30, 2022
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal CancerHikari Chidimatsu, Ryouichi Tsunedomi, Yuki Nakagami, et al.BMC Cancer|October 17, 2022
CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision ruleYuki Nakagami, Shoichi Hazama, Nobuaki Suzuki, et al.Oncology Reports|March 3, 2018
IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptidesShinsuke Kanekiyo, Shoichi Hazama, Hiroko Takenouchi, et al.Annals of Surgical Oncology|May 24, 2023
IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal CancerTsunenori Yamamoto, Ryouichi Tsunedomi, Masao Nakajima, et al.International Journal of Clinical Oncology|April 12, 2020
Serum LOX-1 is a novel prognostic biomarker of colorectal cancerChiyo Nakashima-Nakasuga, Shoichi Hazama, Nobuaki Suzuki, et al.Pageof 8